Review on t(11;16)(q23;q24), with data on clinics, and the genes involved.
. Partial karyogram representing the t(11;16)(q23;q24) (Zerkalenkova et al., 2018) . Clinics and pathology
Disease
Acute monoblastic leukaemia (AML-M5a)
Epidemiology
Poorly defined, only one case described to date, a 15 years-old boy with AML-M5a relapse (Zerkalenkova et al., 2018) .
Treatment
The patient was treated according to AML-BFM-2004 protocol and remission was achieved after the 2nd induction course. After two years a bone marrow relapse of AML M5a was diagnosed.
Prognosis
The prognosis was poor, the current patient died due to the progression of the disease (Zerkalenkova et al., 2018) .
Cytogenetics
Probes MLL dual color break apart rearrangement probe.
Additional anomalies
del(7p) 2 . The probe was hybridized to metaphase and displayed 3'-portion of KMT2A translocated to chromosome 16 (Zerkalenkova et al., 2018) . (Yuan et al., 2010) .
Genes involved and proteins

KMT2A (lysine (K)-specific methyltransferase 2A)
Result of the chromosomal anomaly
Hybrid gene KMT2A/USP10 fusion gene was detected by LDI-PCR (Zerkalenkova et al., 2018) . Description KMT2A/USP10 fusion gene contains 5'-portion of KMT2A and 3'-portion of USP10. Breakpoints are localized in KMT2A intron 12 and USP10 intron 1.
Fusion protein
Description KMT2A/USP10 fusion protein joins amino-acid residue 1493 of KMT2A to amino-acid residue 8 of USP10 thus retaining KMT2A AT hooks, Pro-rich, and the Zn finger CXXC type domains and almost entire USP10.
